Titin copy number variations associated with dominant inherited phenotypes
-
Published:2023-11-07
Issue:
Volume:
Page:jmg-2023-109473
-
ISSN:0022-2593
-
Container-title:Journal of Medical Genetics
-
language:en
-
Short-container-title:J Med Genet
Author:
Perrin AurélienORCID, Métay Corinne, Savarese MarcoORCID, Ben Yaou Rabah, Demidov German, Nelson Isabelle, Solé Guilhem, Péréon Yann, Bertini Enrico SilvioORCID, Fattori Fabiana, D'Amico Adele, Ricci Federica, Ginsberg Mira, Seferian Andreea, Boespflug-Tanguy Odile, Servais Laurent, Chapon Françoise, Lagrange Emmeline, Gaudon Karen, Bloch Adrien, Ghanem Robin, Guyant-Maréchal Lucie, Johari Mridul, Van Goethem Charles, Fardeau Michel, Morales Raul Juntas, Genetti Casie A, Marttila Minttu, Koenig Michel, Beggs Alan HORCID, Udd BjarneORCID, Bonne Gisèle, Cossée MireilleORCID
Abstract
BackgroundTitinopathies are caused by mutations in the titin gene (TTN). Titin is the largest known human protein; its gene has the longest coding phase with 364 exons. Titinopathies are very complex neuromuscular pathologies due to the variable age of onset of symptoms, the great diversity of pathological and muscular impairment patterns (cardiac, skeletal muscle or mixed) and both autosomal dominant and recessive modes of transmission. Until now, only few CNVs inTTNhave been reported without clear genotype–phenotype associations.MethodsOur study includes eight families with dominant titinopathies. We performed next-generation sequencing or comparative genomic hybridisation array analyses and found CNVs in theTTNgene. We characterised these CNVs by RNA sequencing (RNAseq) analyses in six patients’ muscles and performed genotype–phenotype inheritance association study by combining the clinical and biological data of these eight families.ResultsSeven deletion-type CNVs in theTTNgene were identified among these families. Genotype and RNAseq results showed that five deletions do not alter the reading frame and one is out-of-reading frame. The main phenotype identified was distal myopathy associated with contractures. The analysis of morphological, clinical and genetic data and imaging let us draw new genotype–phenotype associations of titinopathies.ConclusionIdentifyingTTNCNVs will further increase diagnostic sensitivity in these complex neuromuscular pathologies. Our cohort of patients enabled us to identify new deletion-type CNVs in theTTNgene, with unexpected autosomal dominant transmission. This is valuable in establishing new genotype–phenotype associations of titinopathies, mainly distal myopathy in most of the patients.
Funder
Boston Children’s Hospital IDDRC Molecular Genetics Core Facility The French Muscular Dystrophy Association Solve-RD project has received funding from the European Union’s Horizon 2020 research and innovation programme Muscular Dystrophy Association
Subject
Genetics (clinical),Genetics
|
|